However, Stryker’s overall net sales remained relatively flat (0.1 percent decrease) on a constant currency bias.
The company’s orthopedic implant sales increased 5.1 percent on a constant currency basis, and medical/surgical equipment sales decreased 7.7 percent on a constant currency basis.
Stryker anticipates an unfavorable impact on net sales of approximately 1.5-2.5 percent in the third quarter of 2009 and an unfavorable impact on net sales of approximately 2-3 percent for the full year of 2009, according to the release.
Read the release on Stryker’s Q2 earnings.
